KUBTEC is the industry leader in digital specimen radiography and the pioneer behind the world's first tomosynthesis specimen imaging system. We firmly believe that there's nothing more critical in breast cancer surgery than achieving clear margins. Our cutting-edge technology has been proven to reduce re-excision rates by an impressive 50%, while also preserving healthy breast tissue. By providing surgeons with the confidence of clear margins during surgery, we ultimately aim to significantly improve patient outcomes. At KUBTEC, our commitment to innovation and patient well-being drives us to continuously push the boundaries of medical technology, ensuring better outcomes for those affected by breast cancer.